Showing results (231-240 of 275) with videos related to

Sort By:
Pageof 28
Blood|January 31, 2009
Novel roles for erythroid Ankyrin-1 revealed through an ENU-induced null mouse mutantGerhard Rank, Rosemary Sutton, Vikki Marshall, et al.
Annals of Emergency Medicine|May 4, 2023
Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled TrialRyan P McCormack, John Rotrosen, Phoebe Gauthier, et al.
Leukemia|April 28, 2016
Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signallingC S Tremblay, F C Brown, M Collett, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined ImmunodeficiencySamantha L Ginn, Claus V Hallwirth, Sophia H Y Liao, et al.
Leukemia|January 23, 2021
T-ALL can evolve to oncogene independenceHesham Abdulla, Anh Vo, Benjamin J Shields, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 3, 2013
β-Hydroxy-β-methylbutyrate (HMB)-free acid attenuates circulating TNF-α and TNFR1 expression postresistance exerciseJeremy R Townsend, Maren S Fragala, Adam R Jajtner, et al.
Leukemia|January 23, 2025
Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemiaCedric S Tremblay, Jesslyn Saw, Feng Yan, et al.
Canadian Family Physician Medecin De Famille Canadien|October 13, 2023
Lipid-lowering therapies for cardiovascular disease prevention and management in primary care: PEER umbrella systematic review of systematic reviewsNicolas Dugré, Adrienne J Lindblad, Danielle Perry, et al.
Contemporary Clinical Trials|March 19, 2021
The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED InnovationGail D'Onofrio, Kathryn F Hawk, Andrew A Herring, et al.
Nature Immunology|October 20, 2020
A new lymphoid-primed progenitor marked by Dach1 downregulation identified with single cell multi-omicsDaniela Amann-Zalcenstein, Luyi Tian, Jaring Schreuder, et al.
Pageof 28